Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00259-024-06753-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Authors' response to "Comment on 'Getting midwives back to hospitals: A discrete choice experiment'".
Int J Nurs Stud
December 2024
WHU Otto-Beisheim School of Management, Germany. Electronic address:
Reply to Comment on Real-world incidence of incident noninfectious uveitis in patients treated with BRAF inhibitors: a nationwide cohort study.
Am J Ophthalmol
December 2024
Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address:
Comment on "Tonic stretch reflex threshold as a measure of disordered motor control and spasticity - A critical review" by Levin et al. (2024).
Clin Neurophysiol
December 2024
Center for Neuroscience and Neurological Recovery, Methodist Rehabilitation Center, Jackson, MS, USA.
Using T-Cell Subsets to Better Characterize Immunoresiliency and Immunodeficiency in Patients with Recurrent Infections.
Infect Dis Rep
December 2024
Department of Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA.
Background/objectives: Common Variable Immunodeficiency Disease (CVID) and other immunodeficiencies can present in subtle and variable ways. Whether or not a genetic lesion can be identified, there are not well understood biomarkers that quantitatively describe how severe a deficiency is. Here we discuss two possible ranking systems, CD4/CD8 T cell ratios and Immune Health Grades, and how such data maybe applicable to some immunodeficiencies.
View Article and Find Full Text PDFGeneral commentary: GQIcombi application to subdue glioma via differentiation therapy.
Front Oncol
December 2024
Department of Neurosurgery, Affiliated Haimen Hospital of Xinglin College, Nantong University, Nantong, Jiangsu, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!